Status:

COMPLETED

A Dose Finding Study of Topically Applied I-020201 as an Adjunct to Good Standard-of-care in Patients With Chronic Diabetic Foot Ulcers

Lead Sponsor:

Kuros Biosurgery AG

Conditions:

Diabetic Foot Ulcer

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Although major improvements in the management and treatment of diabetic foot ulcers have been made, the clinical and financial burden of such long-term wounds is still high and is likely to increase a...

Eligibility Criteria

Inclusion

  • male or female, aged ≥ 18 years
  • given written informed consent
  • female of childbearing potential with a negative result from the pregnancy test at screening who agrees to use an acceptable birth control method (hormonal or IUD) or abstinence throughout the trial
  • Type 1 or Type 2 Diabetes mellitus with HbA1c =\< 12%
  • with only one diabetic foot ulcer on the foot to be treated on or below the ankle

Exclusion

  • pregnant or breast-feeding
  • known or suspected allergies to any of the components of the I-020201
  • uncontrolled anemia (Hb \< 9 g/dL in females and \< 10 g/dL in males)
  • hypoalbuminemia (albumin \< 3 g/dL)
  • overtly infected target ulcer (as judged by investigator)
  • highly exuding wounds (wounds that require a daily dressing change)
  • osteomyelitis
  • systemic infections
  • acute Charcot foot and severe chronic Charcot deformity
  • ABPI \< 0.7 or ankle systolic pressure \< 70 mm Hg
  • one of the following findings (only 1 out of 3 tests is required):
  • on Doppler waveform analysis on the dorsalis pedis and posterior tibial arteries a monophasic or biphasic flow (with loss of reverse flow) in either foot artery, or
  • a toe: brachial index \< 0.7, or
  • transcutaneous oxygen pressure (TcpO2) \< 40 mm Hg
  • suspicion, presence or history of systemic or local cancer or tumor of any kind

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2012

Estimated Enrollment :

211 Patients enrolled

Trial Details

Trial ID

NCT00915486

Start Date

May 1 2009

End Date

March 1 2012

Last Update

March 16 2012

Active Locations (34)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (34 locations)

1

Diabetologické centrum, I. Interní klinika FN Hradec Králové, Fakultní nemocnice Hradec Králové (21)

Hradec Králové, Czechia, 500 05

2

Interní klinika 2. Lékařské fakulty UK a FN Motol, Fakultní nemocnice Motol (22)

Prague, Czechia, 150 06

3

Oddelení diabetologie - Podiatricka ambulance Krajská zdravotní a.s.- Masarykova nemocnice v Ústí nad Labem o.z. (23)

Ústí nad Labem, Czechia, 401 13

4

Lékařský dum Ormiga Angiologická a diabetologická ambulance (20)

Zlín, Czechia, 760 01